Kiora Pharmaceuticals
Quarterly Financials
| Values in thousands | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $-15,951 |
Gross Profit | -38 | -31 | -19 | -15,985 |
EBITDA | -578 | -2,254 | -2,054 | -2,399 |
EBIT | -616 | -2,258 | -2,055 | -2,405 |
Net Income | 26 | -2,152 | -2,192 | -4,223 |
Net Change In Cash | 0 | 0 | 0 | -15,951 |
Free Cash Flow | -1,273 | -3,835 | -2,704 | -2,207 |
Cash | 5,508 | 1,028 | 3,771 | 3,792 |
Basic Shares | 4,361 | 3,989 | 4,217 | 3,000 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $16,000 | $0 | $0 | $12 |
Gross Profit | 16,000 | -4,027 | -134 | -227 |
EBITDA | 5,700 | -12,360 | -13,646 | -13,911 |
EBIT | 5,681 | -12,412 | -13,688 | -13,956 |
Net Income | 3,594 | -12,513 | -13,583 | -13,770 |
Net Change In Cash | 16,000 | 0 | 0 | 12 |
Free Cash Flow | 8,552 | -9,556 | -10,428 | -10,739 |
Cash | 3,792 | 2,454 | 5,964 | 7,854 |
Basic Shares | 4,125 | 538 | 732 | 241 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | $0.01 |
2025-06-30 | -$0.54 |
2025-03-31 | -$0.52 |
2024-12-31 | -$1.20 |
